Metal Oxide Nanoparticles as Novel Contrast Agents for Optical Diagnostics and Laser Treatment of Arthritis

E.N. Sobol; Yu.M. Soshnikova; A.I. Omelchenko; O.I. Baum; A.B. Shekter; P.Yu. Gulyaev; V.V. Lunin

doi:10.1364/CANCER.2016.JTu3A.27

Biomedical Optics 2016
OSA Technical Digest (online) (Optica Publishing Group, 2016),
paper JTu3A.27
•https://doi.org/10.1364/CANCER.2016.JTu3A.27

Metal Oxide Nanoparticles as Novel Contrast Agents for Optical Diagnostics and Laser Treatment of Arthritis

E.N. Sobol, Yu.M. Soshnikova, A.I. Omelchenko, O.I. Baum, A.B. Shekter, P.Yu. Gulyaev, and V.V. Lunin

Cancer Imaging and Therapy 2016

Fort Lauderdale, Florida United States
25–28 April 2016
ISBN: 978-1-943580-10-1

From the session
Joint Poster Session II (JTu3A)

Not Accessible

Your library or personal account may give you access

Get PDF
Email
Share
Get Citation
Copy Citation Text
E. N. Sobol, Y. M. Soshnikova, A. I. Omelchenko, O. I. Baum, A. B. Shekter, P. Y. Gulyaev, and V. V. Lunin, "Metal Oxide Nanoparticles as Novel Contrast Agents for Optical Diagnostics and Laser Treatment of Arthritis," in Biomedical Optics 2016, OSA Technical Digest (online) (Optica Publishing Group, 2016), paper JTu3A.27.

Export Citation
- BibTex
- Endnote (RIS)
- HTML
- Plain Text
Citation alert
Save article

Abstract

Biofunctional magnetite and metal oxide bronzes nanoparticles are manufactured and characterized for potential application as absorbing agents in optical diagnostics using OCT, MRI, arthroscopy and for precise localization and control laser treatment of degenerated cartilage.

PDF Article

Previous Article Next Article